Pancreatic ductal adenocarcinoma: The Vision of Heracles.
Targeting multiple overlooked factors, the Heracles Protocol offers a comprehensive approach to make pancreatic ductal adenocarcinoma more treatable.
- Why it matters: PDAC is highly lethal because it evolves rapidly and develops resistance through complex ecological interactions, not just KRAS mutations, creating a critical need for innovative strategies.
- What they did: The study combines spatial-functional-proteogenomic classification, AI pathology, exosomal delivery, and CRISPR synergy mapping in a protocol that measures, primes, strikes, and adapts to tumor biology.
- The result: This integrated approach aims to improve interception and treatment of PDAC by addressing its multifaceted resistance mechanisms, potentially transforming clinical outcomes.